Compare BOLT & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOLT | MRM |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 8.7M |
| IPO Year | 2021 | 2020 |
| Metric | BOLT | MRM |
|---|---|---|
| Price | $4.96 | $0.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 24.0K | ★ 24.7K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $133.33 | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $0.26 | $0.72 |
| 52 Week High | $7.35 | $4.45 |
| Indicator | BOLT | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 35.91 |
| Support Level | $4.33 | N/A |
| Resistance Level | $5.05 | $1.26 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 43.48 | 22.22 |
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.